Status:
UNKNOWN
Effect Of High Tone Power Therapy On Selected Symptoms In Post Covid Syndrome
Lead Sponsor:
October 6 University
Conditions:
Rehabilitation
Eligibility:
All Genders
40-60 years
Phase:
NA
Brief Summary
The Coronavirus Disease 2019 (COVID-19) is a highly transmittable and pathogenic viral infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2), which emerged in Wuhan, China i...
Detailed Description
The Coronavirus Disease 2019 (COVID-19) is a highly transmittable and pathogenic viral infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2), which emerged in Wuhan, China i...
Eligibility Criteria
Inclusion
- All patients were diagnosed with COVID-19 by polymerase chain reaction (PCR) test of a nasopharyngeal sample during acute phase, completed CBC, lymphocyte inflammatory marker, c-reactive protein and ESR.
- Patients must be negative polymerase chain reaction (PCR).
- Patients will be completely recovered from acute symptoms of covid-19.
- Patients will be recruited after 2- 4 weeks post complete recovery from acute symptoms
Exclusion
- • Patients with feverish systemic or local bacterial infections.
- Epilepsy.
- Pregnant women patients.
- Cancer.
- Uncontrolled Diabetes milletus \>250 mg/dl
Key Trial Info
Start Date :
November 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 20 2022
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT05217771
Start Date
November 10 2021
End Date
November 20 2022
Last Update
February 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emad
Cairo, Egypt